The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Sugar-sweetened beverage intake and risk of oral cavity cancer: Results from 3 prospective US cohort studies.
 
Luis Gomez Castillo
No Relationships to Disclose
 
Armita Norouzi
No Relationships to Disclose
 
Kara Cushing-Haugen
No Relationships to Disclose
 
Rocco Ferrandino
No Relationships to Disclose
 
Zain Rizvi
No Relationships to Disclose
 
Neal D. Futran
Consulting or Advisory Role - Stryker
 
Emily Marchiano
No Relationships to Disclose
 
Cristina P. Rodriguez
Consulting or Advisory Role - Abbvie (I); ADC Therapeutics (I); AstraZeneca (I); beigene (I); Coherus Biosciences; Incyte (I); Karyopharm Therapeutics (I); Kite, a Gilead company (I); Millenium Pharamceuticals (I); Vaccitech
Research Funding - Adagene (Inst); AstraZeneca/MedImmune (Inst); Ayala Pharmaceuticals (Inst); Bayer (Inst); Bayer (Inst); BeiGene (Inst); BeiGene (Inst); Bristol-Myers Squibb (Inst); CUE Biopharma (Inst); Denovo Biopharma (Inst); Denovo Biopharma (Inst); Genentech (Inst); Ignyta (Inst); Incyte (Inst); Kura Oncology (Inst); Merck (Inst); NCCN/Lilly (Inst); OncoC4 (Inst); Portola Pharmaceuticals (Inst); Prelude Therapeutics (Inst); Sanofi/Aventis (Inst); Seagen (Inst)
 
Holly Harris
No Relationships to Disclose
 
Brittany Barber
No Relationships to Disclose